Subbu Nambi
Stock Analyst at Guggenheim
(3.50)
# 881
Out of 5,148 analysts
72
Total ratings
41.94%
Success rate
9.12%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NAUT Nautilus Biotechnology | Maintains: Buy | $2.5 → $4 | $2.32 | +72.41% | 2 | Feb 27, 2026 | |
| WAT Waters | Reiterates: Buy | $440 | $307.23 | +43.22% | 1 | Feb 10, 2026 | |
| TWST Twist Bioscience | Maintains: Buy | $77 → $79 | $45.89 | +72.15% | 3 | Jan 26, 2026 | |
| SOPH SOPHiA GENETICS | Maintains: Buy | $6 → $7 | $4.62 | +51.52% | 2 | Jan 26, 2026 | |
| PSNL Personalis | Maintains: Buy | $12 → $13 | $9.06 | +43.49% | 2 | Jan 26, 2026 | |
| ILMN Illumina | Maintains: Buy | $144 → $170 | $132.89 | +27.93% | 5 | Jan 26, 2026 | |
| GRAL GRAIL | Maintains: Buy | $100 → $130 | $52.63 | +147.01% | 3 | Jan 26, 2026 | |
| GH Guardant Health | Maintains: Buy | $115 → $135 | $92.23 | +46.37% | 8 | Jan 26, 2026 | |
| CSTL Castle Biosciences | Maintains: Buy | $43 → $47 | $27.99 | +67.92% | 3 | Jan 26, 2026 | |
| BRKR Bruker | Maintains: Buy | $53 → $58 | $39.81 | +45.69% | 5 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $21 | $16.12 | +30.27% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $11.15 | +7.62% | 4 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $50 | $36.01 | +38.85% | 5 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $270 | $200.17 | +34.89% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $275 | $206.00 | +33.50% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $103.35 | - | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $170 | $74.20 | +129.11% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $95.59 | - | 1 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $95 | $53.31 | +78.20% | 4 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $20.66 | +74.25% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $8.21 | +21.80% | 1 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.01 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $23.14 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $124.97 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.62 | - | 1 | Dec 14, 2023 |
Nautilus Biotechnology
Feb 27, 2026
Maintains: Buy
Price Target: $2.5 → $4
Current: $2.32
Upside: +72.41%
Waters
Feb 10, 2026
Reiterates: Buy
Price Target: $440
Current: $307.23
Upside: +43.22%
Twist Bioscience
Jan 26, 2026
Maintains: Buy
Price Target: $77 → $79
Current: $45.89
Upside: +72.15%
SOPHiA GENETICS
Jan 26, 2026
Maintains: Buy
Price Target: $6 → $7
Current: $4.62
Upside: +51.52%
Personalis
Jan 26, 2026
Maintains: Buy
Price Target: $12 → $13
Current: $9.06
Upside: +43.49%
Illumina
Jan 26, 2026
Maintains: Buy
Price Target: $144 → $170
Current: $132.89
Upside: +27.93%
GRAIL
Jan 26, 2026
Maintains: Buy
Price Target: $100 → $130
Current: $52.63
Upside: +147.01%
Guardant Health
Jan 26, 2026
Maintains: Buy
Price Target: $115 → $135
Current: $92.23
Upside: +46.37%
Castle Biosciences
Jan 26, 2026
Maintains: Buy
Price Target: $43 → $47
Current: $27.99
Upside: +67.92%
Bruker
Jan 26, 2026
Maintains: Buy
Price Target: $53 → $58
Current: $39.81
Upside: +45.69%
Jan 26, 2026
Maintains: Buy
Price Target: $20 → $21
Current: $16.12
Upside: +30.27%
Jan 9, 2026
Maintains: Buy
Price Target: $8 → $12
Current: $11.15
Upside: +7.62%
Jan 5, 2026
Maintains: Buy
Price Target: $45 → $50
Current: $36.01
Upside: +38.85%
Jan 5, 2026
Maintains: Buy
Price Target: $230 → $270
Current: $200.17
Upside: +34.89%
Jan 5, 2026
Maintains: Buy
Price Target: $250 → $275
Current: $206.00
Upside: +33.50%
Nov 21, 2025
Downgrades: Neutral
Price Target: n/a
Current: $103.35
Upside: -
Oct 29, 2025
Maintains: Buy
Price Target: $115 → $170
Current: $74.20
Upside: +129.11%
Oct 16, 2025
Initiates: Neutral
Price Target: n/a
Current: $95.59
Upside: -
Sep 26, 2025
Maintains: Buy
Price Target: $80 → $95
Current: $53.31
Upside: +78.20%
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $20.66
Upside: +74.25%
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $8.21
Upside: +21.80%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $5.01
Upside: -
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $23.14
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $124.97
Upside: -
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.62
Upside: -